Publications by authors named "Lara Pippo"

Claim this Profile
D
Design organization and clinical processes around patient characteristics: Evidence from a multiple case study of Hemophilia.
Stefano Villa, Raimondo De Cristofaro, Giovanni Di Minno, Simone Laratro, Flora Peyvandi, Lara Pippo

Health Serv Manage Res· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Not Available].
Claudio Jommi, Giovanni Apolone, Giovanna Scroccaro, Valentina Acciai, Antonio Addis, Lara Pippo

Glob Reg Health Technol Assess· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of the Economic Impact of Belimumab for the Treatment of Systemic Lupus Erythematosus in the Italian Setting: A Cost-Effectiveness Analysis.
Francesca Pierotti, Ilaria Palla, Maarten Treur, Lara Pippo, Giuseppe Turchetti

PLoS One· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BUDGET IMPACT ANALYSIS OF BELIMUMAB IN TREATING SYSTEMIC LUPUS ERYTHEMATOSUS.
Francesca Pierotti, Iaria Palla, Lara Pippo, Valentina Lorenzoni, Giuseppe Turchetti

Int J Technol Assess Health Care· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Health technology assessment of belimumab: a new monoclonal antibody for the treatment of systemic lupus erythematosus.
Maria Lucia Specchia, Chiara de Waure, Maria Rosaria Gualano, Andrea Doria, Giuseppe Turchetti, Lara Pippo

Biomed Res Int· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Community-acquired pneumonia: a budget impact model].
Massimo Giusti, Francesco Banfi, Francesco Perrone, Andrea Pitrelli, Lara Pippo

Infez Med· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis and pharmacological characterization of constrained analogues of Vestipitant as in vitro potent and orally active NK(1) receptor antagonists.
Fabio M Sabbatini, Romano Di Fabio, Cristiana Griffante, Giorgio Pentassuglia, Laura Zonzini, Lara Pippo

Bioorg Med Chem Lett· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis